# Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction

> **NCT03704376** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 125 (actual)

## Conditions studied

- Anterior Cruciate Ligament Injury

## Interventions

- **DRUG:** 30 ml of 0.2% ropivacaine
- **DRUG:** 15 ml of 0.2% ropivacaine
- **DRUG:** 100 mcg clonidine
- **DEVICE:** High-frequency linear ultrasound transducer

## Key facts

- **NCT ID:** NCT03704376
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2017-11-16
- **Final completion:** 2017-11-16
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2021-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03704376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03704376, "Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03704376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*